Abstract
Asphyxiated neonates often have hypotension, shock and poor tissue perfusion. Various inotropic medications are commonly used to provide the cardiovascular support to improve the blood pressure and to treat shock. However, there is a paucity of literature on the systemic and regional hemodynamic effects of these inotropic medications in asphyxiated neonates, necessitating cautious translation of findings from other clinical populations and animal studies. This review discusses the current available information, from both clinical studies and animal models of neonatal asphyxia, on commonly used mediations including dopamine, dobutamine, epinephrine, milrinone, levosimendan and hydrocortisone.
Keywords: Newborn, asphyxia, inotropes, catecholamines, blood pressure
Current Pediatric Reviews
Title: Inotropic Therapies in Asphyxiated Neonates: The Clinical and Laboratory Facts
Volume: 5 Issue: 2
Author(s): Chloe Joynt and Po-Yin Cheung
Affiliation:
Keywords: Newborn, asphyxia, inotropes, catecholamines, blood pressure
Abstract: Asphyxiated neonates often have hypotension, shock and poor tissue perfusion. Various inotropic medications are commonly used to provide the cardiovascular support to improve the blood pressure and to treat shock. However, there is a paucity of literature on the systemic and regional hemodynamic effects of these inotropic medications in asphyxiated neonates, necessitating cautious translation of findings from other clinical populations and animal studies. This review discusses the current available information, from both clinical studies and animal models of neonatal asphyxia, on commonly used mediations including dopamine, dobutamine, epinephrine, milrinone, levosimendan and hydrocortisone.
Export Options
About this article
Cite this article as:
Joynt Chloe and Cheung Po-Yin, Inotropic Therapies in Asphyxiated Neonates: The Clinical and Laboratory Facts, Current Pediatric Reviews 2009; 5 (2) . https://dx.doi.org/10.2174/157339609788185712
DOI https://dx.doi.org/10.2174/157339609788185712 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
AMPA Glutamate Receptors and Neuropathic Pain
Mini-Reviews in Medicinal Chemistry Pharmacological and Surgical Therapy for Primary Postpartum Hemorrhage
Current Pharmaceutical Design The Use of Thiazides in Chronic Kidney Disease
Current Hypertension Reviews A Multicenter, Double-Blind, Placebo-Controlled Trial of the PDE9A Inhibitor, PF-04447943, in Alzheimer's Disease
Current Alzheimer Research The Effects of Drugs Used in Anaesthesia on Platelet Membrane Receptors and on Platelet Function
Medicinal Chemistry Reviews - Online (Discontinued) Adverse Drug Reactions in Hospitals: A Narrative Review
Current Drug Safety Targeting the Endocannabinod System to Limit Myocardial and Cerebral Ischemic and Reperfusion Injury
Current Pharmaceutical Biotechnology Phospholipase A2 Myotoxins from Bothrops Snake Venoms: Structure- Function Relationship
Current Organic Chemistry Urocortin: Cardiovascular Actions and Therapeutic Implications
Letters in Drug Design & Discovery Perivascular Adipose Tissue, Inflammation and Vascular Dysfunction in Obesity
Current Vascular Pharmacology Medical Applications of Collagen and Collagen-Based Materials
Current Medicinal Chemistry The Possible Therapeutic Actions of Peroxisome Proliferator-Activated Receptor α(PPARα) Agonists,PPARγ Agonists,3-Hydroxy-3- Methylglutaryl Coenzyme A (HMG-CoA)Reductase Inhibitors,Angiotensin Converting Enzyme (ACE)Inhibitors and Calcium (Ca)-Antagonists on Vascular Endothelial Cells
Current Drug Targets - Cardiovascular & Hematological Disorders Interventions Against Sarcopenia in Older Persons
Current Pharmaceutical Design Nitric Oxide in Asthma Therapy
Current Pharmaceutical Design Stereospecific Synthesis of m-Hydroxymexiletine Enantiomers
Drug Metabolism Letters Fatal Disseminated Toxoplasmosis During Primary HIV Infection
Current HIV Research Resurgence of Herbal Antihypertensives in Management of Hypertension
Current Hypertension Reviews The Role of Liver Biopsy to Assess Alcoholic Liver Disease
Reviews on Recent Clinical Trials Prolonged Exposure to Ketamine Increases Brain Derived Neurotrophic Factor Levels in Developing Rat Brains
Current Drug Safety Exploiting Novel Cell Cycle Targets in the Development of Anticancer Agents
Current Cancer Drug Targets